Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$56.94 USD

56.94
5,112,835

+0.47 (0.83%)

Updated Sep 10, 2024 04:00 PM ET

After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (235 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Mark Vickery headshot

ADP Jobs +324K Still Higher than Expected; CVS, KHC, HUM Report

ADP Chief Economist Nela Richardson said, "The economy is doing better than expected... we continue to see a slowdown in pay growth without broad-based job loss."

CVS Health (CVS) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for CVS Health (CVS) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

CVS Health (CVS) Tops Q2 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 4.25% and 2.52%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) to Report Q2 Earnings: What's in the Cards?

We expect brand price inflation, new product launch, higher utilization and new PBM clients to have contributed to second-quarter growth for CVS Health (CVS).

Earnings Preview: CVS Health (CVS) Q2 Earnings Expected to Decline

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed at $75.95 in the latest trading session, marking a +1.2% move from the prior day.

Zacks Industry Outlook Highlights CVS Health, Herbalife, Rite Aid and Amazon

CVS Health, Herbalife, Rite Aid and Amazon have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

The Zacks Retail Pharmacy and Drugstore industry players like CVS, HLF and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed at $72.31 in the latest trading session, marking a +1.6% move from the prior day.

Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

CVS Health (CVS) Launches Caremark Cost Saver With a New Pact

CVS Health (CVS) is able to dynamically shop for the lowest price on its clients' behalf with the help of Caremark Cost Saver solution.

Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $70.46, marking a -1.14% move from the previous day.

CVS Health (CVS) Stock Moves -0.07%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $69.54, marking a -0.07% move from the previous day.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

CVS Health (CVS) closed at $68.14 in the latest trading session, marking a -0.79% move from the prior day.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) backed by the acquisition of Oak Street Health, which broadens its value-based primary care platform.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed the most recent trading day at $69.41, moving +0.93% from the previous trading session.

CVS Health (CVS) Retail Arm Continues to Grow Amid Rising Costs

CVS Health (CVS) continues to give high priority to digital engagement, after surpassing 50 million unique digital customers in the first quarter.

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Sheraz Mian headshot

Top Analyst Reports for PepsiCo, AbbVie & Honeywell

Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc. (PEP), AbbVie Inc. (ABBV) and Honeywell International Inc. (HON).

CVS Health (CVS) Invests in Renewable Energy With New Pact

CVS Health (CVS) to receive clean, renewable energy through a 12-year agreement with Constellation.

CVS Heath (CVS) MinuteClinic Earns 6th Health Care Approval

CVS Heath's (CVS) MinuteClinic has an in-clinic Net Promotor Score of more than 81, putting it in the top customer rankings.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed at $71.75 in the latest trading session, marking a +0.38% move from the prior day.

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.